Antibiotics can be used to treat a single animal with clinical disease or a large group of animals. In many countries, antibiotics are commonly added to commercial feed for growth promotion in chickens. Antibiotics have effectively improved the rate and efficiency of gain in swine, cattle, and poultry. The different applications of antibiotics in food animals have been described as therapeutic use, prophylactic use, and subtherapeutic use. The global Veterinary antibiotics market is driven by end-use verticals consisting of dairy, meat industry applications. The increasing consumer preference for various dairy products and the rise in companion animal ownership is expected to increase the demand. Increasing animal disease outbreaks and increasing initiatives concerning animal health and welfare is anticipated to further strengthen its demand over the forecast period.
The Global Veterinary Antibiotics market is categorized on the basis of product, End-Users, and region. On the basis of Product Type, the market is segmented into Anti-parasitic, Anti-Bacterial, Non-steroidal anti-inflammatory drug, and Others. On the basis of End-users Mode Type, the market is segmented into Dairy Farm, Poultry Farm, and Others. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. On the other hand, Asia-Pacific is expected to dominate the market during the analysis of the forecast period.
The report further identifies detailed competitive intelligence of Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale S.A., Crystal Pharma, Dechra Pharmaceuticals PLC, Huvepharma AD, Eli Lilly Company, Elanco, Merck & Co., Inc., Sanofi S.A., Vetoquinol S.A., Virbac, Zoetis, Inc., Inovet Group, Dopharma, and Other Prominent Players.
Key Factors Covered in Competitive Landscape
- Company Overview
- Financial Performance
- Key Development
- Latest Strategic Developments
